Astrana Health, Inc. (ASTH)

NASDAQ: ASTH · Real-Time Price · USD

37.55

+1.68 (4.68%)

At close: Oct 9, 2026, 4:00 PM EDT

37.01

-0.54 (-1.44%)

After-hours: Oct 9, 2026, 7:30 PM EDT

Astrana Health Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	3,844	3,182	2,035	1,387	1,144	773.92
Revenue Growth	58.91%	56.39%	46.72%	21.19%	47.84%	12.62%
Gross Profit	402	341.53	271.39	214.96	199.48	177.77
Operating Income	111.88	98.13	89.35	84.61	104.27	98.18
Net Income	40.55	22.49	43.15	60.72	45.17	68.92
Earnings Per Share	0.82	0.46	0.90	1.29	0.99	1.52
EPS Growth	56.77%	-49.09%	-30.23%	30.30%	-34.87%	50.50%

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Intersegment Elimination	-466.83	-338.24	-206.61	-152.12	-124.26	-90.54
Care Partners	3,633	3,023	1,949	1,284	1,051	709.71
Care Delivery	338.73	250.74	136.67	117.94	95.78	46.69
Care Enablement	339.54	246.66	155.45	135.82	120.2	107.69
Total	3,844	3,182	2,035	1,387	1,144	773.92

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	400.79	429.59	290.83	296.31	293.59	286.51
Total Debt	979.41	1,078	470.68	321.27	229.36	202.08
Net Cash (Debt)	-578.62	-648.54	-179.85	-24.96	64.23	84.43
Net Cash Growth	-	-	-	-	-23.93%	13741.15%
Net Cash Per Share	-11.69	-13.14	-3.75	-0.53	1.41	1.86

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	107.87	114.6	52.2	68.23	82.13	70.34
Capital Expenditures	-13.49	-10.11	-8.03	-28.53	-22.94	-19.22
Free Cash Flow	94.38	104.49	44.17	39.7	59.19	51.11
Free Cash Flow Growth	-22.16%	136.58%	11.26%	-32.93%	15.80%	13.58%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	10.46%	10.73%	13.34%	15.50%	17.43%	22.97%
Operating Margin	2.91%	3.08%	4.39%	6.10%	9.11%	12.69%
Pretax Margin	1.56%	1.24%	3.97%	6.48%	7.57%	10.05%
Profit Margin	1.05%	0.71%	2.12%	4.38%	3.95%	8.91%
FCF Margin	2.46%	3.28%	2.17%	2.86%	5.17%	6.60%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 11, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	45.80	55.34	35.89	28.10	29.84	47.57
Forward PE	22.28	29.95	25.02	30.62	65.76	63.35
P/FCF Ratio	20.36	11.91	35.07	42.98	22.77	64.15
PS Ratio	0.50	0.39	0.76	1.23	1.18	4.24